Dependence, addiction and overdose risk

Human and animal research has demonstrated that BZP is similar to other central nervous system stimulants such as amphetamines, methamphetamines, and MDMA (ecstasy), but at about one tenth the strength. Given BZP’s similarity to other stimulants, it is likely that people who use BZP are at similar risk of harm, though the reduced potency of BZP means overdose is less likely. Hospital admissions have most commonly occurred when users have mixed BZP with other substances.